eMedicine Specialties > Radiology > Musculoskeletal

Neuropathic Arthropathy (Charcot Joint)

Author: Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, Consultant Radiologist, North Manchester General Hospital, The Pennine Acute NHS Trust, Manchester UK
Coauthor(s): Muthusamy Chandramohan, MBBS, DMRD, FRCR, Consultant Radiologist, Bradford Teaching Hospitals, UK; Ian Turnbull, MB, ChB, MD, DMRD, FRCR, Lecturer, Department of Radiology, University of Manchester; Consulting Neuroradiologist, Hope Hospital, Salford, Manchester and North Manchester General Hospital, UK; Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute
Contributor Information and Disclosures

Updated: May 27, 2008

Introduction

Background

Neuropathic osteoarthropathy can be defined as bone and joint changes that occur secondary to loss of sensation and that accompany a variety of disorders. Charcot first described the relationship between loss of sensation and arthropathy in 1868.

The radiographic changes include destruction of articular surfaces, opaque subchondral bones, joint debris, deformity, and dislocation. Neuropathic arthropathy poses a special problem in imaging when it is associated with a soft tissue infection.1,2,3,4,5,6,7

Neuropathic arthropathy (Charcot joint). Osteolys...

Neuropathic arthropathy (Charcot joint). Osteolysis of the distal metatarsals and phalanges with tapering results in a pencil-like appearance in the late stage of diabetic neuropathy.

Neuropathic arthropathy (Charcot joint). Osteolys...

Neuropathic arthropathy (Charcot joint). Osteolysis of the distal metatarsals and phalanges with tapering results in a pencil-like appearance in the late stage of diabetic neuropathy.


Neuropathic arthropathy (Charcot joint). CT scan ...

Neuropathic arthropathy (Charcot joint). CT scan of the ankle in a patient with neuropathic arthropathy. Note the destruction of the articular surface, disorganization of the joint, and fragmentation.

Neuropathic arthropathy (Charcot joint). CT scan ...

Neuropathic arthropathy (Charcot joint). CT scan of the ankle in a patient with neuropathic arthropathy. Note the destruction of the articular surface, disorganization of the joint, and fragmentation.


Pathophysiology

The pathophysiology of neuropathic arthropathy is debatable. The general consensus is that the loss of proprioception and deep sensation leads to recurrent trauma, which ultimately leads to progressive destruction, degeneration, and disorganization of the joint. Another theory postulates that neurally mediated vascular reflex results in hyperemia, which can cause osteoclastic bone resorption.

Causes of neuropathic arthropathy include the following:

One of the joint manifestations of leprosy are the signs of Charcot's disease. Charcot's disease of leprosy advances despite treatment.9

Neuropathic osteoarthropathy can be classified into hypertrophic and atrophic types. Hypertrophic changes predominate in the upper motor neuron lesions, and atrophic changes occur in peripheral nerve injuries. The early stage of osteoarthritis simulates neuropathic osteoarthropathy, both radiologically and pathologically.

Progressive joint effusion, fracture, fragmentation, and subluxation should raise the suspicion of neuroarthropathy. In the advanced stage, abnormal findings on radiographs include subchondral sclerosis, osteophytosis, subluxation, and soft tissue swelling. Long-standing neuroarthropathy is characterized by disorganization of joints. The finding of considerable amounts of cartilaginous and osseous debris within the synovial membrane (termed detritic synovitis) should alert the pathologist that the changes may represent a neuropathic joint. Other causes of detritic synovitis include osteonecrosis, calcium pyrophosphate dihydrate crystal deposition disease, psoriatic arthritis, osteoarthritis, and osteolysis with detritic synovitis.

Frequency

United States

The overall incidence in the United States appears to be the same as that found internationally. Approximately 15% of patients with diabetes appear to have neuropathic arthropathy.

International

Neuropathic arthropathy is seen in 10-20% of patients with tabes dorsalis and in 20-25% of patients with syringomyelia.

Mortality/Morbidity

Mortality and morbidity are related to the disease process, the cause of the disease, and the related complications. Morbidity is worsened by the development of soft tissue infection and osteomyelitis.

Race

Diabetes-related neuroarthropathy appears to be more common in the Western population, whereas neuroarthropathy associated with infection, such as in tabes and leprosy, is common in developing countries. No racial predilection has been documented in steroid-induced neuropathic osteoarthropathy.

Sex

In general, no sex predilection has been recorded; however, neuroarthropathy related to connective tissue disorders, such as scleroderma, appears to be more common in females. Neuroarthropathy related to alcoholism and trauma is more common in males.

Age

Neuropathic arthropathy related to diabetes, syphilis, leprosy, and connective tissue disorders is more common in the elderly population. Neuroarthropathy related to asymbolia, spina bifida, and spinal trauma is more common in young individuals. Sensory impairment associated with spina bifida and myelomeningocele is the most frequent cause of neuropathic arthropathy in childhood.

Presentation

Joint changes usually precede neurologic deficit. The affected joint is usually swollen and warm but is not painful. Pain may be noted at presentation in one third of patients, but the response to deep pain and proprioception may be reduced.

Preferred Examination

Radiography may be the only imaging required. In the appropriate clinical setting, a fairly accurate diagnosis can be achieved. The roles of ultrasonography and CT are limited. Ultrasonography and CT can be helpful in identifying any local collection, and they can be used to guide aspiration cytology. The role of MRI and radionuclide scanning is to differentiate soft tissue infection from osteomyelitis.10,11

Limitations of Techniques

Radiographic findings in the early stages may simulate osteoarthritis. Radiographs may not demonstrate findings that help in diagnosing osteomyelitis in neuropathic joints, which is a common problem.

The roles of ultrasonography and CT are limited. Ultrasonography can be used to identify any local collection when infection occurs and to guide aspiration for cytologic analysis; however, it provides no further information regarding the integrity of underlying bone. Although CT may be helpful in evaluating cortical destruction, sequestra, and intraosseous gas, these changes are not specific for neuropathic arthropathy.

The role of MRI and radionuclide scanning is to differentiate soft tissue infection from osteomyelitis. Bone marrow edema is nonspecific and has several causes; therefore, differentiating bone marrow edema from neuropathic arthropathy may not be possible on the basis of MRI findings alone. Similarly, enhanced bone activity on radionuclide scans is a nonspecific finding and may occur with several neoplastic, inflammatory, and degenerative processes.

Differential Diagnoses

Calcium Pyrophosphate Deposition Disease
Osteoarthritis, Primary

Other Problems to Be Considered

Osteoarthritis
Calcium pyrophosphate dihydrate crystal deposition disease
Osteonecrosis
Posttraumatic osteoarthritis
Infection
Alkaptonuria

In the early stage, neuropathic arthropathy can simulate osteoarthritis. Bone fragmentation and collapse are seen in osteonecrosis, posttraumatic osteoarthritis, intra-articular steroid injection, infection, and alkaptonuria.

More on Neuropathic Arthropathy (Charcot Joint)

Overview: Neuropathic Arthropathy (Charcot Joint)
Imaging: Neuropathic Arthropathy (Charcot Joint)
Follow-up: Neuropathic Arthropathy (Charcot Joint)
Multimedia: Neuropathic Arthropathy (Charcot Joint)
References

References

  1. Bar-On E, Floman Y, Sagiv S, et al. Orthopaedic manifestations of familial dysautonomia. A review of one hundred and thirty-six patients. J Bone Joint Surg Am. Nov 2000;82-A(11):1563-70. [Medline].

  2. Bloomgarden ZT. American Diabetes Association 60th Scientific Sessions, 2000: the diabetic foot. Diabetes Care. May 2001;24(5):946-51. [Medline].

  3. Deirmengian CA, Lee SG, Jupiter JB. Neuropathic arthropathy of the elbow. A report of five cases. J Bone Joint Surg Am. Jun 2001;83-A(6):839-44. [Medline].

  4. Jones EA, Manaster BJ, May DA, Disler DG. Neuropathic osteoarthropathy: diagnostic dilemmas and differential diagnosis. Radiographics. Oct 2000;20 Spec No:S279-93. [Medline].

  5. Kapila A, Lines M. Neuropathic spinal arthropathy: CT and MR findings. J Comput Assist Tomogr. Jul-Aug 1987;11(4):736-9. [Medline].

  6. Sommer TC, Lee TH. Charcot foot: the diagnostic dilemma. Am Fam Physician. Nov 1 2001;64(9):1591-8. [Medline].

  7. Sanders LJ. What lessons can history teach us about the Charcot foot?. Clin Podiatr Med Surg. Jan 2008;25(1):1-15. [Medline].

  8. Koop I, Loreck D, Krause A. Diabetic neuropathic arthropathy. Arthritis Rheum. Apr 1999;42(4):806. [Medline].

  9. Rostom S, Bahiri R, Mahfoud-Filali S, Hajjaj-Hassouni N. Neurogenic osteoarthropathy in leprosy. Clin Rheumatol. Dec 2007;26(12):2153-5. [Medline].

  10. Soysal N, Ayhan M, Guney E, Akyol A. Differential diagnosis of Charcot arthropathy and osteomyelitis. Neuro Endocrinol Lett. Oct 2007;28(5):556-9. [Medline].

  11. Devendra D, Farmer K, Bruce G, et al. Diagnosing osteomyelitis in patients with diabetic neuropathic osteoarthropathy. Diabetes Care. Dec 2001;24(12):2154-5. [Medline].

  12. Wagner SC, Schweitzer ME, Morrison WB, et al. Can imaging findings help differentiate spinal neuropathic arthropathy from disk space infection? Initial experience. Radiology. Mar 2000;214(3):693-9. [Medline].

  13. Palestro CJ, Mehta HH, Patel M, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med. Feb 1998;39(2):346-50. [Medline].

  14. Alnafisi N, Yun M, Alavi A. F-18 FDG positron emission tomography to differentiate diabetic osteoarthropathy from septic arthritis. Clin Nucl Med. Jul 2001;26(7):638-9. [Medline].

  15. Basu S, Chryssikos T, Houseni M, Scot Malay D, Shah J, Zhuang H, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?. Nucl Med Commun. Jun 2007;28(6):465-72. [Medline].

  16. Judge MS. Infection and neuroarthropathy: the utility of C-reactive protein as a screening tool in the Charcot foot. J Am Podiatr Med Assoc. Jan-Feb 2008;98(1):1-6. [Medline].

  17. Naqvi A, Cuchacovich R, Saketkoo L, Espinoza LR. Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up. Am J Med Sci. Feb 2008;335(2):145-8. [Medline].

  18. Noonan KJ, Didelot WP, Lindseth RE. Care of the pediatric foot in myelodysplasia. Foot Ankle Clin. Jun 2000;5(2):281-304, vi. [Medline].

  19. Pitocco D, Collina MC, Musella T, Ruotolo V, Caputo S, Manto A, et al. Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy. Horm Metab Res. Mar 2008;40(3):163-4. [Medline].

  20. Sliwa JA, Rippe D, Do V. Charcot spine in a person with congenital insensitivity to pain with anhydrosis: a case report of re-diagnosis. Arch Phys Med Rehabil. Mar 2008;89(3):568-71. [Medline].

  21. Sutterfield R. Light therapy and advanced wound care for a neuropathic plantar ulcer on a Charcot foot. J Wound Ostomy Continence Nurs. Jan-Feb 2008;35(1):113-5; discussion 116-7. [Medline].

Further Reading

Keywords

neurotrophic joint, neuropathic joint disease, neuroarthropathy, Charcot joint disease, arthropathy, neuropathic osteoarthropathy, destruction of articular surfaces, dense subchondral bones, joint debris, joint deformity, dislocation, hypertrophic neuropathic osteoarthropathy, atrophic neuropathic osteoarthropathy, disorganized joints

Contributor Information and Disclosures

Author

Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, Consultant Radiologist, North Manchester General Hospital, The Pennine Acute NHS Trust, Manchester UK
Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR is a member of the following medical societies: American Association for the Advancement of Science, American Institute of Ultrasound in Medicine, British Medical Association, British Society of Interventional Radiology, Royal College of Physicians, Royal College of Physicians and Surgeons of the United States, Royal College of Radiologists, and Royal College of Surgeons of England
Disclosure: Nothing to disclose.

Coauthor(s)

Muthusamy Chandramohan, MBBS, DMRD, FRCR, Consultant Radiologist, Bradford Teaching Hospitals, UK
Disclosure: Nothing to disclose.

Ian Turnbull, MB, ChB, MD, DMRD, FRCR, Lecturer, Department of Radiology, University of Manchester; Consulting Neuroradiologist, Hope Hospital, Salford, Manchester and North Manchester General Hospital, UK
Disclosure: Nothing to disclose.

Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute
Sumaira MacDonald, MBChB, PhD, MRCP, FRCR is a member of the following medical societies: British Medical Association, Royal College of Physicians, and Royal College of Radiologists
Disclosure: Nothing to disclose.

Medical Editor

Amilcare Gentili, MD, Clinical Professor of Radiology, University of California at San Diego; Consulting Staff, Department of Radiology, Thornton Hospital
Amilcare Gentili, MD is a member of the following medical societies: American Roentgen Ray Society, Radiological Society of North America, and Society of Skeletal Radiology
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Wilfred CG Peh, MD, MBBS, FRCP(Glasg), FRCP(Edin), FRCR, Clinical Professor, Faculty of Medicine, National University of Singapore; Senior Consultant Radiologist, Alexandra Hospital, Singapore
Wilfred CG Peh, MD, MBBS, FRCP(Glasg), FRCP(Edin), FRCR is a member of the following medical societies: American Roentgen Ray Society, British Institute of Radiology, International Skeletal Society, Radiological Society of North America, Royal College of Physicians, and Royal College of Radiologists
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, Resolution Imaging Medical Corporation
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Felix S Chew, MD, MBA, EdM, Professor, Department of Radiology, Vice Chairman for Radiology Informatics, Section Head of Musculoskeletal Radiology, University of Washington
Felix S Chew, MD, MBA, EdM is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.